‹ All Posts
Finkhoz Roboadvisory Services

29th Jul · SEBI-Registered Analyst

STARHEALTH

Fundamental: Revenue +13.92% YoY | PAT verdict — Strong | Operating Margin 5.81% (+352 bps) | P/E 32.5x vs sector 60.2x (46% discount; below own 10Y avg 39.6x) | Upside 15.82% | ROCE 11.36% | 5Y Revenue CAGR 14% | Rank #2/13 peers | Rating 8.00 Technical: Consolidating near recent highs post strong rally — above all key MAs, broader bullish trend intact | 5/9/13 EMAs closely aligned as immediate dynamic support | RSI ~57 — healthy, room to extend | ADX ~36 — strong underlying trend | MACD mild corrective phase Moat: India's largest standalone health insurer with 14 million+ policyholders and a dominant individual health insurance franchise — scale advantages in claims management, hospital network depth (14,000+ hospitals), and brand recognition in retail health insurance create a durable competitive position that general insurers struggle to replicate. View: Ranked #2 in the insurance segment with a perfect valuation score (10/10), trading at a 46% P/E discount to peers and below its own historical average — massive operating margin expansion (+352 bps) signals the profitability turnaround is underway; a high-quality health insurance compounder at one of the most attractive valuations in the sector.

#EquityResearch#FundamentalViews#TechnicalViews#WatchOutFor
460 likes·64 comments